Tilray Brands, Inc.
TLRY · XNASCIK 1731348fmd_0SHD5DKV3J0PXJYKE0DYGT6HHEManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2016 to Aug 31, 2026, 48 periods
| Line item | FY2019 | FY2020 | FY2020 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | 405 | – | 513 | 628 | 627 | 789 | 821 | 915 |
| Cost of revenue | – | – | 309 | – | 390 | 512 | 480 | 566 | 581 | 655 |
| Gross profit | – | – | 96 | – | 123 | 117 | 147 | 223 | 241 | 260 |
| Realized investment gains (losses) | – | 0 | – | (2) | – | – | – | – | – | – |
| Research and development | – | – | 2 | – | 1 | 2 | 1 | 1 | 0 | 0 |
| Selling, general and administrative | – | 175 | – | 141 | – | – | – | – | – | – |
| Total operating expenses | 182 | – | 200 | – | 255 | 727 | 1,517 | 398 | 2,523 | 323 |
| Operating income | – | – | (104) | – | (132) | (610) | (1,370) | (175) | (2,283) | (63) |
| Interest expense | – | – | 26 | – | 31 | 40 | 47 | 49 | 41 | 30 |
| Interest and investment income | – | 0 | – | – | 3 | 12 | 33 | 13 | 11 | 6 |
| Other non-operating income (expense) | – | – | 14 | – | (185) | 198 | (67) | (38) | 10 | (1) |
| Income before taxes | – | – | (109) | – | (345) | (441) | (1,450) | (249) | (2,302) | (88) |
| Income tax expense | – | – | (8) | – | (9) | (7) | (7) | (27) | (121) | 17 |
| Net income from continuing operations | – | – | (101) | – | (336) | (434) | (1,443) | (222) | (2,181) | (105) |
| Net income | – | – | (103) | – | (367) | (477) | (1,453) | (245) | (2,187) | (121) |